Annual report pursuant to Section 13 and 15(d)

Related Party Transactions (Details Narrative)

v3.20.2
Related Party Transactions (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Jun. 12, 2020
Feb. 12, 2020
Jul. 31, 2020
Jul. 31, 2020
Jul. 31, 2019
Accrued consulting fees     $ 3,097,881 $ 3,097,881 $ 1,702,886
Share based payment award options grants shares        
Consulting Agreement [Member] | Chief Scientific Officer [Member]          
Agreement description The Company amended the consulting agreement, extending the term of the existing agreement until December 12, 2020. The Company entered into a consulting agreement with the spouse of the Company's Chief Scientific Officer. The term of the agreement is four months and can be extended by written agreement.      
Lease term   4 months      
Consulting Agreement [Member] | Consultant [Member]          
Accrued consulting fees     $ 100,000 $ 100,000  
Share based payment award options grants shares       30,000  
Share based payment award options date of grant       $ 48,000  
Stock options exercisable term       10 years  
Grants in period, weighted average exercise price       $ 1.56